BioCentury
ARTICLE | Clinical News

Bardoxolone methyl regulatory update

April 27, 2015 7:00 AM UTC

FDA granted Orphan Drug designation to Reata’s bardoxolone to treat pulmonary arterial hypertension (PAH). The small molecule activator of nuclear factor (erythroid-derived 2)-like 2 ( NFE2L2; NRF2)...